🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This clinical study is in subjects who are 18 years old or older with local...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-04-21
Trial ID
NCT02301143
Treatments Being Tested
This is a multicenter, randomized controlled, phase III clinical trial. The...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2020-03-01
Trial ID
NCT03907826
Treatments Being Tested
The purpose of this study is to determine if the use of exploratory immunol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2013-07-05
Trial ID
NCT01899989
Treatments Being Tested
The purpose of this study is to compare induction chemotherapy (gemcitabine...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2013-11
Trial ID
NCT01872962
Treatments Being Tested
The purpose of study is to compare bladder intact-event free survival (BI-E...
Status
Active Not Recruiting
Location
Loma Linda Univ Faculty Medic
Start Date
2020-12-07
Trial ID
NCT04658862
This is a single-center, open-label, phase I study designed to determine th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2022-10-31
Trial ID
NCT05325281
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867